期刊文献+

陕西省HIV/AIDS患者生存时间回顾性队列研究 被引量:14

Survival of HIV/AIDS Patients in Shanxi Province: a Retrospective Cohort Study
下载PDF
导出
摘要 目的描述陕西省HIV/AIDS患者生存时间的分布特征,探讨其影响因素。方法采用回顾性队列研究方法,使用寿命表描述HIV/AIDS患者的生存时间,Cox模型分析其影响因素。结果 2415例HIV血清学阳性患者经确证检测后的中位生存时间为8.61年。越早开始治疗(RR=8.08×10-11),治疗持续时间越长(RR=6.35×10-11),患者死亡危险越低。未治疗患者,确证检测年龄延迟(RR=1.04),死亡危险增加;及时检测CD4水平(RR=0.20),死亡危险降低。疾病状态进展为AIDS、文化程度低、母婴传播都是影响生存时间的危险因素。结论及时检测和尽早治疗是HIV/AIDS患者长期生存的重要保护因素,三级预防策略适用于艾滋病防治。 Objective The aim of this study was to describe survival time of HIV/AIDS patients in Shaanxi Province and to ex- plore its influencing factors. Methods In this retrospective cohort study, survival time of HIV/AIDS patients was described using life ta- ble. And COX model was used to analyze influencing factors. Results 2415 cases of patients were collected with a median survivai time of 8.61 years. Early treatment( RR = 8. 08 x 10 - 11 ) and long duration of treatment( RR = 6. 35 x 10 - 11 ) were protective factors for survival of HIV/AIDS patients. The course of disease of AIDS, the low level of education and mother-to-child transmission are the risk factors af- fecting survival time. Conclusion HIV detected in time and early treatments are important protective factors for long-term survival of HIV/AIDS patients. Epidemiological tertiary levels of prevention strategy are more applicable to the current situation of AIDS prevention.
出处 《中国卫生统计》 CSCD 北大核心 2014年第2期213-216,共4页 Chinese Journal of Health Statistics
关键词 艾滋病 生存时间 队列研究 AIDS Survival time Cohort study
  • 相关文献

参考文献10

  • 1Joint United Nations Programme on HIV/AIDS. Global report: UN- AIDS report on the global AIDS epidemic. Geneva, Switzerland:Joint United Nations Programme on HIV/AIDS ,2010.
  • 2Morgan D,Mahe C,Mayanja B ,et al. H1V - 1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS ,2002,16(4 ) :597 -603.
  • 3Vanhems P,Baratin D,Allard R,et al. Factors associated with the time elapsed between the initial detection of HIV - 1 antibodies and a diag- nosis of AIDS among patients followed in Lyons University Hospitals. CIS1H Collaborators. Sexually transmitted infections, 1999, 75 ( 6 ) : 389 - 39l.
  • 4Abaasa AM, Todd J, Ekoru K, et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care pro- gramme : the experience of The AIDS Support Organization ( TASO), Kampala, Uganda. BMC health services research,2008,8:241.
  • 5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV - 1 infec- tion with early antiretroviral therapy. The New England journal of medi- cine,2011,365(6) :493 -505.
  • 6Hentrich M, Maretta L, Chow KU, et al. Highly active antiretroviral therapy (HAART) improves survival in I-I/V - associated Hodgkin's dis- ease:results of a multicenter study. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO,2006,17 (6) : 914 -919.
  • 7Alemu AW, Sebastian MS. Determinants of survival in adult HIV pa- tients on antiretroviral therapy in Oromiyaa, Ethiopia. Global health ac- tion,2010,3.
  • 8Obel N, Omland LH, Kronborg G, et al. Impact of non - HIV and HIV risk factors on survival in H1V - infected patients on HAART : a popula- tion - based nationwide cohort study. PIoS one,2011,6 ( 7 ) : e22698.
  • 9Colvin CJ. H1V/AIDS, chronic diseases and globalisation. Globalization and health,2011,7:31.
  • 10Scandlyn J. When AIDS became a chronic disease. The Western journal of medicine,2000,172 ( 2 ) : 130 - 133.

同被引文献108

引证文献14

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部